The UArizona College of Pharmacy's scientists, labs and alumni are partnering with pharmaceutical companies, working in hospital emergency departments, and helping the public get the medication they need as we face the COVID-19 pandemic. Included in this effort are BIO5 members Drs. Jun Wang and Chris Hulme, both of which have shifted their research foci toward COVID-19. Dr. Wang is working on developing promising drug candidates that inhibit SARS-CoV-2 virus in cell culture, while Dr. Hulme is researching the pharmacological underpinnings of COVID-19.
Related
